Document ID: FDA-2019-N-0803-0001
Agency: fda
Document Type: Notice
Title: Advisory Committee; Technical Electronic Product Radiation Safety
Standards Committee; Renewal
Posted Date: 2019-04-02T04:00Z

[Federal Register Volume 84, Number 63 (Tuesday, April 2, 2019)]
[Notices]
[Page 12616]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06360]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2019-N-0803]

Advisory Committee; Technical Electronic Product Radiation Safety 
Standards Committee; Renewal

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; renewal of advisory committee.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
renewal of the Technical Electronic Product Radiation Safety Standards 
Committee (Committee) by the Commissioner of Food and Drugs (the 
Commissioner). The Commissioner has determined that it is in the public 
interest to renew the Committee for an additional 2 years beyond the 
charter expiration date. The new charter will be in effect until 
December 24, 2020.

DATES: Authority for the Technical Electronic Product Radiation Safety 
Standards Committee would have expired on December 24, 2018, unless the 
Commissioner formally determined that renewal is in the public 
interest.

FOR FURTHER INFORMATION CONTACT: Patricio Garcia, Center for Devices 
and Radiological Health, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 66, Rm. G610, Silver Spring, MD 20993-0002, 301-
796-6875, [email protected].

SUPPLEMENTARY INFORMATION: Pursuant to 41 CFR 102-3.65 and approval by 
the Department of Health and Human Services pursuant to 45 CFR part 11 
and by the General Services Administration, FDA is announcing the 
renewal of the Committee. The Committee is a non-discretionary Federal 
advisory committee established to provide advice and consultation to 
the Commissioner. The Commissioner of Food and Drugs is charged with 
the administration of the Radiation Control for Health and Safety Act 
of 1968. This act creates the Committee and requires the Commissioner 
to consult with the Committee before prescribing standards for 
radiation emissions from electronic products. This Committee provides 
advice and consultation to the Commissioner of Food and Drugs on the 
technical feasibility, reasonableness, and practicability of 
performance standards for electronic products to control the emission 
of radiation from such products and may recommend electronic product 
radiation safety standards to the Commissioner for consideration.
    The Committee shall consist of a core of 15 voting members, 
including the Chair. Members and the Chair are selected by the 
Commissioner or designee from among authorities knowledgeable in the 
fields of science or engineering applicable to electronic product 
radiation safety. Members will be invited to serve for overlapping 
terms of up to 4 years. Terms of more than 2 years are contingent upon 
the renewal of the Committee by appropriate action prior to its 
expiration. The core of voting members will include five members 
selected from governmental agencies, including State and Federal 
Governments, five members from the affected industries, and five 
members from the general public, of which at least one shall be a 
representative of organized labor. A quorum shall consist of 10 
members, of which at least 3 shall be from the general public, 3 from 
the government agencies, and 3 from the affected industries.
    Further information regarding the most recent charter and other 
information can be found at https://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Radiation-EmittingProducts/TechnicalElectronicProductRadiationSafetyStandardsCommittee/default.htm 
or by contacting the Designated Federal Officer (see FOR FURTHER 
INFORMATION CONTACT). In light of the fact that no change has been made 
to the committee name or description of duties, no amendment will be 
made to 21 CFR 14.100.
    This document is issued under the Federal Advisory Committee Act (5 
U.S.C. app.). For general information related to FDA advisory 
committees, please visit us at https://www.fda.gov/AdvisoryCommittees/default.htm.

    Dated: March 27, 2019.
Lowell J. Schiller,
Commissioner of Food and Drugs.
[FR Doc. 2019-06360 Filed 4-1-19; 8:45 am]
 BILLING CODE 4164-01-P